These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 24974473)
1. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients]. Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473 [TBL] [Abstract][Full Text] [Related]
2. Lack of interaction of gabapentin with carbamazepine or valproate. Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239 [TBL] [Abstract][Full Text] [Related]
3. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid. Minkova GD; Getova DP Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330 [TBL] [Abstract][Full Text] [Related]
4. Developmental and therapeutic pharmacology of antiepileptic drugs. Miura H Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504 [TBL] [Abstract][Full Text] [Related]
5. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents. Steinborn B; Galas-Zgorzalewicz B Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261 [TBL] [Abstract][Full Text] [Related]
6. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy. Suemaru K; Kawasaki H; Yasuhara K; Yao K; Furuno K; Kawakami Y; Araki H; Gomita Y; Oka E Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740 [TBL] [Abstract][Full Text] [Related]
7. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate]. Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769 [TBL] [Abstract][Full Text] [Related]
8. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid. Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099 [TBL] [Abstract][Full Text] [Related]
9. Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. Kong ST; Lim SH; Lee WB; Kumar PK; Wang HY; Ng YL; Wong PS; Ho PC PLoS One; 2014; 9(9):e108190. PubMed ID: 25255292 [TBL] [Abstract][Full Text] [Related]
10. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy. Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy. Chen ZJ; Wang XD; Wang HS; Chen SD; Zhou LM; Li JL; Shu WY; Zhou JQ; Fang ZY; Zhang Y; Huang M Seizure; 2012 Mar; 21(2):110-7. PubMed ID: 22055352 [TBL] [Abstract][Full Text] [Related]
12. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients. Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730 [TBL] [Abstract][Full Text] [Related]
13. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children. Liu H; Delgado MR Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448 [TBL] [Abstract][Full Text] [Related]
14. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491 [TBL] [Abstract][Full Text] [Related]
15. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Pisani F; Fazio A; Oteri G; Ruello C; Gitto C; Russo F; Perucca E Epilepsia; 1986; 27(5):548-52. PubMed ID: 3093212 [TBL] [Abstract][Full Text] [Related]
16. Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients. McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ Epilepsy Res; 1992 May; 11(3):193-8. PubMed ID: 1396534 [TBL] [Abstract][Full Text] [Related]
17. Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study. Rakic Ignjatovic A; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M Br J Clin Pharmacol; 2009 Feb; 67(2):199-208. PubMed ID: 19076986 [TBL] [Abstract][Full Text] [Related]
18. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents. Steinborn B Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]